Louis G. Lange

Companies

• NewAmsterdam Pharma Co N.V.Board member Dec 29, 2023 to now¹
• Epiphany Technology Acquisition Corp.Board member Oct 4, 2022 to Oct 4, 2022²
• BioPlus Acquisition Corp.Board member Dec 2, 2021 to Dec 2, 2021³
• CymaBay Therapeutics (United States)Board member Oct 11, 2013 to Jun 30, 2015⁴
• Esperion TherapeuticsBoard member Jun 25, 2013 to Jul 1, 2013⁵
• MaxygenBoard member Jun 1, 2007 to Jun 7, 2012⁶
• Gilead SciencesEVP Cardiovascular Therapeutic Apr 27, 2009 to May 8, 2009⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NPNewAmsterdam Pharma Co N.V. NAMS10,360 shares⁸$210.2K at $20.29Mar 11, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 11, 2026Sold 446 shares at $31.23 of NewAmsterdam Pharma Co N.V.⁸
• Mar 11, 2026Sold 44,173 shares at $30.41 of NewAmsterdam Pharma Co N.V.⁸
• Mar 9, 2026Exercised 44,619 shares at $11.50 of NewAmsterdam Pharma Co N.V.⁹
• Mar 6, 2026Sold 28,186 shares at $29.41 of NewAmsterdam Pharma Co N.V.⁹
• Jan 7, 2026Granted 3,400 shares of NewAmsterdam Pharma Co N.V.¹⁰
• Jun 1, 2025Exercised options 68 shares of NewAmsterdam Pharma Co N.V.¹¹
• May 1, 2025Exercised options 69 shares of NewAmsterdam Pharma Co N.V.¹²
• Apr 14, 2025Exercised options 69 shares of NewAmsterdam Pharma Co N.V.¹³
• Mar 26, 2025Exercised options 3,102 shares of NewAmsterdam Pharma Co N.V.¹⁴
• Jan 7, 2025Granted 6,960 shares of NewAmsterdam Pharma Co N.V.¹⁵
• Feb 13, 2024Bought 5,000 shares at $19.00 of NewAmsterdam Pharma Co N.V.¹⁶